PsyMed Ventures Newsletter

Share this post

How the DEA and FDA will regulate psychedelic medicine

psymedventures.substack.com

How the DEA and FDA will regulate psychedelic medicine

Business Trip, a podcast about psychedelic entrepreneurship

PsyMed Ventures
Jun 28, 2022
1
Share this post

How the DEA and FDA will regulate psychedelic medicine

psymedventures.substack.com

Welcome back to Business Trip, a podcast about psychedelic entrepreneurship! 🍄

In this week’s episode, we chat with Matt Zorn, an attorney at Yetter Coleman. Matt has expertise in DEA law, especially regarding psychedelics. Matt is currently challenging the DEA’s decision to schedule 5 new tryptamines, he recently argued Kathryn Tucker’s psilocybin “Right To Try” case against the DEA, and previously co-led Sue Sisley’s DEA case related to cannabis scheduling and research. He also writes the drug policy newsletter On Drugs.

LISTEN HERE

In this episode, we discuss:

  • How psychedelic companies operate according with FDA and DEA guidelines

  • What psychedelic companies can do to increase their chance of approval

  • How drug scheduling works

  • Matt’s views about classic psychedelics vs. new chemical entities

Listen to the episode here, on Spotify or Apple Podcasts.

When you’re done listening, tweet at us @businesstripfm to share your thoughts!


About Us

Business Trip tells the story of the emerging industry of psychedelics. Each episode features a new company in the field, ranging from biotech startups developing novel compounds, to clinics and retreats for healing, to software companies building tools to power the ecosystem. 

Business Trip is produced by Greg Kubin and Matias Serebrinsky — we’re partners at PsyMed Ventures, advocates of the healing powers of psychedelic medicine and see a bright future ahead for the industry.

Thanks for listening,

Matias and Greg

💖 Know someone who would enjoy Business Trip?

Follow us on Twitter & Instagram.

Share this post

How the DEA and FDA will regulate psychedelic medicine

psymedventures.substack.com
Comments
TopNewCommunity

No posts

Ready for more?

© 2023 Business Trip
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing